Theragenics Corporation^® TGX, a medical device company serving the
surgical products and prostate cancer treatment markets, today announced it
has signed a Supply and Reseller agreement with Accelyon Limited. Under the
three-year agreement, Theragenics will supply its AgX100^® seeds to Accelyon
who will provide for the loading and packaging of the seeds into prescription
loaded needles, custom strands and other configurations. Accelyon will
distribute the finished products in the European Union, Australia and New
Zealand.
“This Agreement is our first major opportunity to penetrate Europe, Australia
and New Zealand with our brachytherapy seed product,” said M. Christine
Jacobs, Chairman and Chief Executive Officer of Theragenics Corporation.
“Accelyon is a new entrant into the brachytherapy marketplace with experienced
talent. The company is managed by industry veterans possessing direct
brachytherapy experience in all these markets. We have expected our AgX100^®
iodine seed to provide opportunities outside of the United States. Accelyon
provides us this access in these important brachytherapy markets. They have
international expertise and reach we do not possess. We are thrilled to begin
a new brachytherapy relationship with Accelyon.”
“Accelyon's people bring a wealth of experience in the European and
Australasia brachytherapy marketplaces,” said Saheed Rashid, Managing Director
of Accelyon. “We understand what is important to customers and are committed
to delivering the highest standards of quality and reliability. Theragenics is
a high quality manufacturer and well-known brand throughout the brachytherapy
world. They share Accelyon's commitment to this important treatment. We are
excited to begin this new relationship with Theragenics.”
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in